Chaim M. Roifman
Division of Immunology/Allergy
Department of Paediatrics
The Hospital for Sick Children
Toronto
Canada
Name/email consistency: high
- Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. Roifman, C.M., Schroeder, H., Berger, M., Sorensen, R., Ballow, M., Buckley, R.H., Gewurz, A., Korenblat, P., Sussman, G., Lemm, G. Int. Immunopharmacol. (2003)
- A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Roifman, C.M., Zhang, J., Chitayat, D., Sharfe, N. Blood (2000)
- Antibody deficiency, growth retardation, spondyloepiphyseal dysplasia and retinal dystrophy: a novel syndrome. Roifman, C.M. Clin. Genet. (1999)